AIDS Patient Care STDS

1. FIRNHABER C, Simoncini G, Mayer C, Armon C, et al
   Mammogram and Pap Smear Uptake Among Women in the HIV Outpatient Study USA, 2010-2021.
   AIDS Patient Care STDS. 2024;38:151-154.
   

   >> Share

   
   

   
   Am J Pathol

2. LIU Q, Zhang X, Jiang X, Zhang C, et al
   A Histopathologic Image Analysis for the Classification of Endocervical Adenocarcinoma Silva Patterns Depend on Weakly Supervised Deep Learning.
   Am J Pathol. 2024;194:735-746.
   

   >> Share

   
   

   
   Arch Gynecol Obstet

3. SCHMITT F, Najjari L, Kupec T, Stickeler E, et al
   Predictors of significant distress in cervical cancer patients: a cross sectional study.
   Arch Gynecol Obstet. 2024 Apr 23. doi: 10.1007/s00404-024-07505.
   

   >> Share

   
   

   
   Biochem Genet

4. HE H, Lin C, Lu Y, Wu H, et al
   Knockdown of miR-24 Suppressed the Tumor Growth of Cervical Carcinoma Through Regulating PTEN/PI3K/AKT Signaling Pathway.
   Biochem Genet. 2024;62:1277-1290.
   

   >> Share

   
   

   
   Biochim Biophys Acta Mol Basis Dis

5. LI C, Xue Y, Wu J, Zhang L, et al
   MTH1 inhibition synergizes with ROS-inducing agents to trigger cervical cancer cells undergoing parthanatos.
   Biochim Biophys Acta Mol Basis Dis. 2024 Apr 22:167190.
   

   >> Share

   
   

   
   Biology (Basel)

6. HUANG L, Zhang J, Songyang Z, Xiong Y, et al
   Identification and Validation of eRNA as a Prognostic Indicator for Cervical Cancer.
   Biology (Basel). 2024;13:227.
   

   >> Share

   
   

   
   BJOG

7. CALVEZ J, Neirynck V, Marcelin AG, Jary A, et al
   Extending vaccination periods against human papillomavirus: Lessons from the SARS-CoV-2 pandemic.
   BJOG. 2024;131:877-879.
   

   >> Share

   
   

   
   BMC Cancer

8. ADAM JA, Poel E, van Eck Smit BLF, Mom CH, et al
   [(18)F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer.
   BMC Cancer. 2024;24:513.
   

   >> Share

   
   

   
   BMC Prim Care

9. BONGAERTS THG, Buchner FL, Nierkens V, Crone MR, et al
   Perceptions and beliefs of general practitioners on their role in the cancer screening programmes in the Netherlands: a mixed-methods study.
   BMC Prim Care. 2024;25:129.
   

   >> Share

   
   

   
   BMC Public Health

10. HOUPERT R, Bendiane MK, Huiart L, Bouhnik AD, et al
    Socioeconomic and cultural factors associated with pap smear screening among French women living in Reunion Island.
    BMC Public Health. 2024;24:1125.
    

    >> Share

    
    
11. NGU SF, Lau LS, Chan CY, Ngan HY, et al
    Acceptability of self-collected vaginal samples for human papillomavirus testing for primary cervical cancer screening: comparison of face-to-face and online recruitment modes.
    BMC Public Health. 2024;24:1104.
    

    >> Share

    
    

    
    BMC Womens Health

12. ATIASE Y, Effah K, Mawusi Wormenor C, Tekpor E, et al
    Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
    BMC Womens Health. 2024;24:260.
    

    >> Share

    
    

    
    BMJ Open

13. BALOGUN FM, Omotade O
    Pursuance of a Yoruba name for cervical cancer in Southwest Nigeria: a case study.
    BMJ Open. 2024;14:e074020.
    

    >> Share

    
    
14. ABDUL-LATIF M, Chowdhury A, Tharmalingam H, Taylor NJ, et al
    Exploratory study of using Magnetic resonance Prognostic Imaging markers for Radiotherapy In Cervix cancer (EMPIRIC): a prospective cohort study protocol.
    BMJ Open. 2024;14:e077390.
    

    >> Share

    
    

    
    Br J Cancer

15. PORTNOY A, Pedersen K, Kim JJ, Burger EA, et al
    Vaccination and screening strategies to accelerate cervical cancer elimination in Norway: a model-based analysis.
    Br J Cancer. 2024 Apr 20. doi: 10.1038/s41416-024-02682.
    

    >> Share

    
    

    
    Brachytherapy

16. SARWAR A, Eminowicz G
    Radiotherapy induced ureteric stenosis in locally advanced cervical cancer: A review of current evidence.
    Brachytherapy. 2024 Apr 19:S1538-4721(24)00044.
    

    >> Share

    
    

    
    Cancer

17. DUSKA LR, Podwika SE, Randall LM
    Top advances of the year: Cervical cancer.
    Cancer. 2024 Apr 23. doi: 10.1002/cncr.35334.
    

    >> Share

    
    
18. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
    National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough.
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35335.
    

    >> Share

    
    
19. RUAN Y, Heer E, Brenner DR
    Reply to "National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough".
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35339.
    

    >> Share

    
    

    
    Cancer Epidemiol Biomarkers Prev

20. CHENG D, Rieu-Werden ML, Lykken JM, Werner CL, et al
    Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings.
    Cancer Epidemiol Biomarkers Prev. 2024.
    

    >> Share

    
    

    
    Cancer Imaging

21. HUANG K, Huang X, Zeng C, Wang S, et al
    Radiomics signature for dynamic changes of tumor-infiltrating CD8+ T cells and macrophages in cervical cancer during chemoradiotherapy.
    Cancer Imaging. 2024;24:54.
    

    >> Share

    
    

    
    Cancer Manag Res

22. TESHOME R, Yang I, Woldetsadik E, Girma E, et al
    Pre- and Post-Treatment Quality of Life Among Patients with Advanced Stage Cervical Cancer at Tikur Anbessa Specialized Hospital, Ethiopia.
    Cancer Manag Res. 2024;16:311-323.
    

    >> Share

    
    

    
    Cancer Rep (Hoboken)

23. HOSSEINI MS, Shafizadeh F, Bahremani MH, Farzaneh F, et al
    Comparison of programmed death-ligand 1 expression in adenocarcinoma and squamous cell carcinoma of the cervix in paraffin blocks of patients with cervical cancer.
    Cancer Rep (Hoboken). 2024;7:e2057.
    

    >> Share

    
    

    
    Cell Mol Biol (Noisy-le-grand)

24. ZHENG L, Ren Q, Zhu W, Tao X, et al
    MiR-4319 targets tuftelin 1 to reduce malignancy of cervical cancer cells.
    Cell Mol Biol (Noisy-le-grand). 2024;70:54-60.
    

    >> Share

    
    

    
    Cells

25. MEHTA H, Ambele MA, Mokgautsi N, Moela P, et al
    Probing the Effects of Retinoblastoma Binding Protein 6 (RBBP6) Knockdown on the Sensitivity of Cisplatin in Cervical Cancer Cells.
    Cells. 2024;13:700.
    

    >> Share

    
    

    
    Chin Clin Oncol

26. LEE J, Lapuz C, Khor R, Lau E, et al
    Narrative review of the utility of magnetic resonance imaging in radiotherapy for cervical cancer.
    Chin Clin Oncol. 2024 Apr 13:cco-23-91. doi: 10.21037.
    

    >> Share

    
    

    
    Clin Cancer Res

27. CHAMBERS L, Haight P, Chalif J, Mehra Y, et al
    Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-Oncology Research.
    Clin Cancer Res. 2024 Apr 25. doi: 10.1158/1078-0432.CCR-23-2570.
    

    >> Share

    
    
28. SIVARS L, Jylha C, Crona Guterstam Y, Zupancic M, et al
    Cell-free human papillomavirus (HPV) DNA is a sensitive biomarker for prognosis and for early detection of relapse in locally advanced cervical cancer.
    Clin Cancer Res. 2024 Apr 26. doi: 10.1158/1078-0432.CCR-23-3941.
    

    >> Share

    
    

    
    Clin Epigenetics

29. FACKLER MJ, Pleas M, Li Y, Soni A, et al
    Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.
    Clin Epigenetics. 2024;16:56.
    

    >> Share

    
    

    
    Diseases

30. PETRE I, Vernic C, Petre I, Vlad CS, et al
    Systematic Review on the Effectiveness and Outcomes of Nivolumab Treatment Schemes in Advanced and Metastatic Cervical Cancer.
    Diseases. 2024;12:77.
    

    >> Share

    
    

    
    Dtsch Arztebl Int

31. GRIEGER P, Eisemann N, Hammersen F, Rudolph C, et al
    Initial Evidence of a Possible Effect of HPV Vaccination on Cancer Incidence in Germany-Focus on Cervical Cancer.
    Dtsch Arztebl Int. 2024;.
    

    >> Share

    
    

    
    Eur J Surg Oncol

32. SABAH J, Menoux I, Eberst L, Lodi M, et al
    Variability of treatment of locally advanced cervical cancer: How French multidisciplinary teams follow European guidelines?
    Eur J Surg Oncol. 2024;50:108281.
    

    >> Share

    
    

    
    Front Oncol

33. LIANG M, Sheng L, Ke Y, Wu Z, et al
    The research progress on radiation resistance of cervical cancer.
    Front Oncol. 2024;14:1380448.
    

    >> Share

    
    

    
    Gynecol Obstet Invest

34. WANG Y, Wang H
    CCT6A regulates cervical cancer cell glycolysis and proliferation under hypoxic conditions via the TCAB1/TERT.
    Gynecol Obstet Invest. 2024 Apr 24. doi: 10.1159/000539042.
    

    >> Share

    
    

    
    Heliyon

35. MA CY, Zhao J, Zhou JY
    Microbiome profiling and Co-metabolism pathway analysis in cervical cancer patients with acute radiation enteritis.
    Heliyon. 2024;10:e29598.
    

    >> Share

    
    
36. SCHLUETER D, Bermudez Y, Debrot KF, Ross LW, et al
    Breast and cervical cancer programs' success in maintaining screening during periods of high COVID-19: A qualitative multi-case study analysis.
    Heliyon. 2024;10:e29223.
    

    >> Share

    
    

    
    Histopathology

37. YASUTAKE N, Yamamoto H, Kuga R, Jiromaru R, et al
    Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
    Histopathology. 2024;84:1178-1191.
    

    >> Share

    
    

    
    Infect Agent Cancer

38. ZHANG Y, Du H, Wang C, Huang X, et al
    Feasibility and applicability of self-sampling based online cervical cancer screening: findings from the China online cervical cancer screening trial.
    Infect Agent Cancer. 2024;19:16.
    

    >> Share

    
    

    
    Int J Gynaecol Obstet

39. ALFAREH M, Obeid D, Alhoshan H, Basri R, et al
    Low uptake of Pap test as a cervical cancer screen among Saudi women: Findings from a national survey.
    Int J Gynaecol Obstet. 2024 Apr 19. doi: 10.1002/ijgo.15532.
    

    >> Share

    
    

    
    Int J Gynecol Cancer

40. VAZQUEZ-VICENTE D, Boria F, Castellanos T, Gutierrez M, et al
    SUCCOR morbidity: complications in minimally invasive versus open radical hysterectomy in early cervical cancer.
    Int J Gynecol Cancer. 2024;34:203-208.
    

    >> Share

    
    
41. CHARNALIA M, Chopra S, Mulani J, Popat P, et al
    RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials.
    Int J Gynecol Cancer. 2024 Apr 22:ijgc-2024-005336.
    

    >> Share

    
    
42. ROSATI A, Certelli C, Ferrandina G, Fanfani F, et al
    Minimally invasive adrenalectomy: a personalized surgical approach in recurrent cervical cancer.
    Int J Gynecol Cancer. 2024 Apr 22:ijgc-2023-005241.
    

    >> Share

    
    

    
    Int J Gynecol Pathol

43. STOLNICU S, Praiss AM, Allison D, Tessier-Cloutier B, et al
    Proposal of Novel Binary Grading Systems for Cervical Squamous Cell Carcinoma.
    Int J Gynecol Pathol. 2024;43:203-214.
    

    >> Share

    
    

    
    Int J Public Health

44. THOMAS-PURCELL K, Bailey A, Sealy DA, Song G, et al
    Cervical Cancer Stigma Among Caribbean Population: A Descriptive Paper.
    Int J Public Health. 2024;69:1606725.
    

    >> Share

    
    

    
    Int J Womens Health

45. TESHOME R, Yang I, Woldetsadik E, Girma E, et al
    Survival Status and Predictors Among Women with Advanced Stage of Cervical Cancer.
    Int J Womens Health. 2024;16:605-617.
    

    >> Share

    
    

    
    Int Rev Cell Mol Biol

46. AGARWAL M, Kumar M, Pathak R, Bala K, et al
    Exploring TLR signaling pathways as promising targets in cervical cancer: The road less traveled.
    Int Rev Cell Mol Biol. 2024;385:227-261.
    

    >> Share

    
    

    
    J Cell Mol Med

47. DATTA S, Verma P, Dhara B, Kundu R, et al
    Interplay of precision therapeutics and MD study: Calocybe indica's potentials against cervical cancer and its interaction with VEGF via octadecanoic acid.
    J Cell Mol Med. 2024;28:e18302.
    

    >> Share

    
    

    
    J Clin Pathol

48. LIU Q, Zhang T, Chen L, Zhou X, et al
    Correlation of immediate prevalence of cervical precancers and cancers with HPV genotype and age in women with ASC-US/hrHPV+: a retrospective analysis of 2292 cases.
    J Clin Pathol. 2023 Jan 18:jcp-2022-208580. doi: 10.1136/jcp-2022-208580.
    

    >> Share

    
    

    
    J Eur Acad Dermatol Venereol

49. SKERLEV M, Ljubojevic Hadzavdic S, Sirotkovic-Skerlev M
    Not all bad with HPV is the cervical cancer only!
    J Eur Acad Dermatol Venereol. 2024;38:796-797.
    

    >> Share

    
    

    
    J Low Genit Tract Dis

50. MOHAMMAD H, Espensen AS, Arnardottir MB, Bergholdt SH, et al
    The Incidence of Cervical Intraepithelial Neoplasia or Cervical Cancer in Women Referred With Postcoital Bleeding.
    J Low Genit Tract Dis. 2024 Apr 23. doi: 10.1097/LGT.0000000000000808.
    

    >> Share

    
    

    
    J Minim Invasive Gynecol

51. BAEKELANDT J
    vNOTES Radical Hysterectomy: A New Approach To Cervical Cancer.
    J Minim Invasive Gynecol. 2024 Apr 18:S1553-4650(24)00173.
    

    >> Share

    
    

    
    J Mol Biol

52. BOLDINOVA EO, Baranovskiy AG, Filina YV, Miftakhova RR, et al
    PrimPol Variant V102A with Altered Primase and Polymerase Activities.
    J Mol Biol. 2024;436:168542.
    

    >> Share

    
    

    
    J Thromb Thrombolysis

53. NETO BV, Tavares V, da Silva JB, Liz-Pimenta J, et al
    Haemostatic gene variations in cervical cancer-associated venous thrombosis: considerations for clinical strategies.
    J Thromb Thrombolysis. 2024 Apr 20. doi: 10.1007/s11239-024-02983.
    

    >> Share

    
    

    
    JAMA Oncol

54. CHO WK, Park W, Kim SW, Lee KK, et al
    Postoperative Hypofractionated Intensity-Modulated Radiotherapy With Concurrent Chemotherapy in Cervical Cancer: The POHIM-CCRT Nonrandomized Controlled Trial.
    JAMA Oncol. 2024 Apr 25. doi: 10.1001/jamaoncol.2024.0565.
    

    >> Share

    
    

    
    Lab Invest

55. ZHONG F, Wang T, Li W, Zhang H, et al
    Associations of Single Versus Multiple Human Papillomavirus Infections With the Prevalence of Cervical Intraepithelial Neoplasia 2/3 and Squamous Cell Carcinoma Lesions: Human Papillomavirus Type-Specific Attribution.
    Lab Invest. 2024;104:100328.
    

    >> Share

    
    

    
    LGBT Health

56. FLEMING J, Grasso C, Mayer KH, Reisner SL, et al
    Gender-Affirming Hormone Therapy and Cervical Cancer Screening Rates in Transgender Men and Nonbinary People: A Cross-Sectional Study from a Boston Community Health Center.
    LGBT Health. 2024 Apr 26. doi: 10.1089/lgbt.2023.0418.
    

    >> Share

    
    
57. MCDOWELL A, Rieu-Werden ML, Atlas SJ, Fields CD, et al
    Characteristics of Clinicians Caring for Transgender Men and Nonbinary Individuals and Guideline Concordance of Clinicians' Cervical Cancer Screening Counseling for Cisgender Individuals Versus Transgender Men and Nonbinary Individuals with a Cervix.
    LGBT Health. 2024 Apr 22. doi: 10.1089/lgbt.2023.0067.
    

    >> Share

    
    

    
    Maturitas

58. VAN DER HOEF C, Bawuah Dsane L, Schuur N, Louwers YV, et al
    Hormone replacement therapy in women with iatrogenic premature ovarian insufficiency after radiotherapy for cervical cancer: A retrospective cohort and survey study.
    Maturitas. 2024;185:108004.
    

    >> Share

    
    

    
    Mol Biol Rep

59. DENG S, Yuan P, Sun J
    The role of NF-kappaB in carcinogenesis of cervical cancer: opportunities and challenges.
    Mol Biol Rep. 2024;51:538.
    

    >> Share

    
    

    
    Pan Afr Med J

60. MAYERI DG, Kahasha PM, Kibalama IB, Mongane J, et al
    Cervical precancerous and cancerous lesions screening using Pap smear test at Provincial Referral Hospital of Bukavu, Eastern DR Congo: profile and recommendations to stakeholders.
    Pan Afr Med J. 2024;47:57.
    

    >> Share

    
    

    
    Pathol Res Pract

61. YIN C, Yu J, Liu G, He J, et al
    Riddle of the Sphinx: Emerging role of circular RNAs in cervical cancer.
    Pathol Res Pract. 2024;257:155315.
    

    >> Share

    
    

    
    Phys Eng Sci Med

62. LEUNG SN, Chandra SS, Lim K, Young T, et al
    Automatic segmentation of tumour and organs at risk in 3D MRI for cervical cancer radiation therapy with anatomical variations.
    Phys Eng Sci Med. 2024 Apr 24. doi: 10.1007/s13246-024-01415.
    

    >> Share

    
    

    
    PLOS Glob Public Health

63. KHOJA L, Wang Y, Haque SE, Ahsan H, et al
    Understanding of cervical cancer, acceptability of HPV self-collection, and prevalence of HPV in a semi-urban setting in Bangladesh.
    PLOS Glob Public Health. 2024;4:e0003157.
    

    >> Share

    
    

    
    PLoS One

64. TIRKASO BH, Bayisa TH, Desta TW
    Histopathologic patterns and factors associated with cervical lesions at Jimma Medical Center, Jimma, Southwest Ethiopia: A two-year cross-sectional study.
    PLoS One. 2024;19:e0301559.
    

    >> Share

    
    
65. MOSHI JM, Ummelen M, Smedts F, Ramaekers FCS, et al
    Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix.
    PLoS One. 2024;19:e0297008.
    

    >> Share

    
    
66. XU F, Carlson SA, Greenlund KJ
    Understanding primary care providers' attitudes towards preventive screenings to patients with inflammatory bowel disease.
    PLoS One. 2024;19:e0299890.
    

    >> Share

    
    
67. ZEBER-LUBECKA N, Kulecka M, Dabrowska M, Baginska-Drabiuk K, et al
    Cervical microbiota dysbiosis associated with high-risk Human Papillomavirus infection.
    PLoS One. 2024;19:e0302270.
    

    >> Share

    
    

    
    Radiat Prot Dosimetry

68. PATODI V, Soni TP, Singh DK, Patni N, et al
    Dosimetric comparison of O-ring versus conventional C-arm linear accelerator for volumetric modulated arc therapy (VMAT) of head and neck cancer and carcinoma cervix patients.
    Radiat Prot Dosimetry. 2024;200:538-543.
    

    >> Share

    
    

    
    Saudi Med J

69. 
    What factors contribute to differences in cervical cancer screening in rural and urban community health centers?
    Saudi Med J. 2024;45:447.
    

    >> Share

    
    

    
    Virol J

70. MA B, Zhou J, Zhou W, Ma Z, et al
    Nonlinear relationship between viral load and TCT in single/multiple HPV52 infection.
    Virol J. 2024;21:90.
    

    >> Share

    
    

    
    World J Clin Cases

71. ALZIBDEH A, Mohamad I, Wahbeh L, Abuhijlih R, et al
    Can we triumph over locally advanced cervical cancer with colossal para-aortic lymph nodes? A case report.
    World J Clin Cases. 2024;12:1851-1856.
    

    >> Share

    
    

    
    World J Surg Oncol

72. YUAN H, Li L, Li N, Yao H, et al
    Sarcoma of the uterine cervix: experience of a single center.
    World J Surg Oncol. 2024;22:104.
    

    >> Share

    
    

    
    Zhonghua Fu Chan Ke Za Zhi

73. LI X, Gao YH, Yang Z, Ma Y, et al
    [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:307-319.
    

    >> Share

    
    
74. ZHANG W, Cao YS, Wei MC, Xu J, et al
    [Application of optical coherence tomography in the evaluation of cervical lesions: a multicenter study].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:299-306.
    

    >> Share

    
    

    
    Zhonghua Nan Ke Xue

75. ZHANG J, Shao SY, Ma YJ, Qin W, et al
    [Cognition of human papillomavirus and its influencing factors among college students in Shandong province].
    Zhonghua Nan Ke Xue. 2023;29:826-830.
    

    >> Share

    
    

    
    Zhonghua Zhong Liu Za Zhi

76. 
    [Specification for quality control of cervical cancer screening (DB11/T 2137-2023)].
    Zhonghua Zhong Liu Za Zhi. 2024;46:269-273.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share